Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis
Clinical trial NCT06162507 · COMPLETED
Trial details
- NCT number
- NCT06162507
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-22
- Primary completion
- 2024-07-04
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.